A newly identified genetic marker may significantly improve the ability to predict life-threatening reactions to the gout medication allopurinol in U.S. patients.
While the gene HLA-B*58:01 has long been used to screen patients in…

A newly identified genetic marker may significantly improve the ability to predict life-threatening reactions to the gout medication allopurinol in U.S. patients.
While the gene HLA-B*58:01 has long been used to screen patients in…